2014

The Global Market for Intravascular Ultrasound Tools and Ancillary Equipment

NEW YORK, July 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

The Global Market for Intravascular Ultrasound Tools and Ancillary Equipment

http://www.reportlinker.com/p01556800/The-Global-Market-for-Intravascular-Ultrasound-Tools-and-Ancillary-Equipment.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

 

Highlights

 

The global intravascular ultrasound technology (IVUS) products market reached $483.7 million in 2012. The market is expected to reach $702 million in 2017 for a compound annual growth rate (CAGR) of 7.7%. The Japanese IVUS products market as a segment was valued at $176.1 million in 2012. It is expected to reach $257.4 million in 2017, a CAGR of 7.9%. The U.S. IVUS products market as a segment was valued at $168.7 million in 2012. It is expected to reach $238 million in 2017, a CAGR of 7.1%.

 

Introduction & Scope

 

This study measures, forecasts and segments the intravascular ultrasound technology (IVUS) market on the basis of products, applications and end users. Geographic analyses of all these markets are also provided in the study. The key products captured in the study include: IVUS consoles (including integrated and cart version consoles). IVUS catheters (including mechanical/rotatory and static electric/phased array catheters). Accessories (pullback devices, guidewires and introducer sheaths, and other accessories). Software. Services. The key applications covered in the study include the following. Coronary applications Diagnostic applications (including lesion characterization/decision on PCI sizing and strategy; assessment of angiographically indeterminate lesions or lesion significance; and other coronary IVUS diagnostic applications). Interventional applications (including guidance for angioplasty; guidance for plaque modification; stent thrombosis and restenosis; and other interventional clinical coronary applications). Research (including drug discovery and development; angioplasty/stents evaluation; atherosclerosis process and others). Noncoronary/peripheral applications (including diagnostic, interventional and research applications). The key end users captured in the study include the following. Hospitals. Stand-alone labs. Research centers and organizations (research work conducted by academic or medical schools is covered in this section). Commercial organizations. The key geographic regions according to which the markets are segmented include: Japan. U.S. Europe. Asia and ROW.

 

STUDY GOALS AND OBJECTIVES

 

The goal of this study is to provide industry participants insights on the IVUS market scenario, both in terms of quantitative as well as qualitative data, which could help them to gain market insights in order to develop business/growth strategies, analyze their position in the current market scenario and make key business decisions in the IVUS market. In particular, the objectives of the study are the following. To provide comprehensive analysis of IVUS products, applications and end-user segments. To identify the market dynamics of each key market and the relevant business impact thereof. To provide market forecasting of products, applications and end users by their respective segments and by the geographic regions mentioned above. To report and analyze key market developments. To highlight and analyze market trends, drivers, restraints and opportunities. To provide key recommendations. To analyze each key geographic region listed above and understand its drivers and restraints. To provide the market shares of key market players, and analyze the competitive scenario of the market.

 

REASONS FOR DOING THE STUDY

 

Intravascular ultrasound (IVUS) is a rapidly growing medical imaging technology, which holds immense potential pertaining to its ability to address unmet requirements in the earlier detection and intervention of coronary artery diseases. Moreover, the popularity of this technology has surged due to its proven advantages (as indicated by some international clinical studies) over traditional angiography. In addition to this, an aging population and rising chronic disease (such as cardiac disease) population is also fueling the market's growth. However, the high cost of IVUS devices/products coupled with the growing need of cost-effective treatment worldwide is restricting the potential market growth. On the other side, different reimbursement scenarios for such devices depict varying degrees of penetration of this technology worldwide. This report presents such issues that are driving and constraining the market growth and probable solutions that can address such concerns. This report also highlights key market strategies, trends and recommendations in addition to providing the quantitative assessment of the market that can help manufacturers and suppliers understand the growth potential of different market segments.

 

SCOPE OF REPORT

 

This report includes only those products, applications and end users that are listed above, and segments the global market by four regions as listed above. The scope of the report includes the following. Key market analysis. Strategic recommendations. Market dynamics (drivers, restraints and opportunities). Forecasted market estimation for 2012 through 2017. Competitive developments and landscape. Geographical analysis. Market share of leading market players. Profiles of key market players. Patents.

 

INTENDED AUDIENCE

 

The key audience for this study includes: IVUS product developers and manufacturers. IVUS market start-ups. Academic and commercial research organizations. Consulting firms. Medical imaging market information database developers. This report will enable the audience to understand and gain insights of the current and changing market scenario. The data provided can help users understand which market segments (products, applications and end users) are expected to growth at higher rates, factors driving growth, factors limiting the growth, key opportunity areas and so on.

 

INFORMATION SOURCES AND METHODOLOGY

 

Because of the nature of the markets involved in this report, the markets were assessed in the top-down method. The content provided in this report including market numbers and forecasts was prepared based on both primary and secondary research methodologies. Market dynamics, qualitative information and views of industry participants were also taken into consideration while forecasting and measuring the market values. Historic and base numbers were derived from primary and secondary methodology. Macro markets were further divided into micro markets in consultation with views of different industry participants. The average of the range of the estimates gathered from primary research was taken, and later validated from, secondary and primary sources. Similarly, data on PCI numbers, IVUS procedures and IVUS penetration rates were gathered both from primary and secondary research. The primary research included interviews and discussions with key industry participants, key opinion leaders and some subject matter experts including healthcare professionals or technicians (such as nurses, doctors, lab technicians). Secondary data were collected from free sources such as Google search, company websites, industry reports and paid sources such as Key notes, Factiva, LexisNexis, etc. In this market study, IVUS use is segmented into three sections at the micro level: research, diagnostics and intervention. Some of the applications categorized under the intervention section may seem to be part of diagnostics; thus, such categories named in this market study are subject to the definitions of each market segment of diagnostics and intervention categories.

 

 

 

CHAPTER 1 INTRODUCTION 2

INTRODUCTION 2

STUDY GOALS AND OBJECTIVES 3

REASONS FOR DOING THE STUDY 3

SCOPE OF REPORT 3

INTENDED AUDIENCE 4

INFORMATION SOURCES AND METHODOLOGY 4

ANALYST CREDENTIALS 5

RELATED BCC REPORTS 5

BCC ONLINE SERVICES 5

DISCLAIMER 5

CHAPTER 2 SUMMARY 7

SUMMARY TABLE GLOBAL IVUS PRODUCTS MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 7

SUMMARY FIGURE GLOBAL IVUS PRODUCTS MARKET BY REGION, 2010-2017 ($

MILLIONS) 7

CHAPTER 3 OVERVIEW 10

IVUS TECHNOLOGY EVOLUTION AND INDUSTRY LIFE CYCLE STAGE 10

IVUS INDUSTRY IN JAPAN - RELATIVELY MATURE MARKET 10

IVUS INDUSTRY WORLDWIDE (EXCEPT JAPAN) - GROWING PHASE 11

IVUS PRODUCT MARKET ANALYSIS 11

FIGURE 1 MARKET SHARE OF KEY PRODUCTS IN IVUS MARKET, 2012 (%) 11

PRODUCT DIFFERENTIATION - IVUS IMAGING SYSTEMS 12

IVUS KEY APPLICATIONS MARKET ANALYSIS 13

FIGURE 2 KEY APPLICATIONS AREAS OF IVUS VERSUS TOTAL APPLICATION,

2010-2017 ($ MILLIONS) 13

IVUS END-USER MARKET ANALYSIS 14

FIGURE 3 MARKET SHARE OF KEY END USERS IN IVUS MARKET, 2012 (%) 14

REGULATORY ENVIRONMENT 15

MARKET DYNAMICS 16

DRIVERS 16

Emergence of Favorable and Positive IVUS Clinical Data 16

Competitive Edge of IVUS over Angiography 17

Technology Advancements, Product Developments and Innovations 17

Collaborations of Some Market Players with Leading Laboratory

Suppliers 19

Growing and Expanding Applications Coupled with a Rise in Stent

Deployments 19

Growing Patient Population, Increasing Burden of Diseases and Rise

in Global Aging Population 20

Lower Penetration of IVUS Worldwide and Declining PCI Rate 20

TABLE 1 APPROXIMATE GLOBAL IVUS PENETRATION IN PCI 2012, BY REGION

(THOUSANDS/%) 21

RESTRAINTS AND CHALLENGES 21

Reimbursement Issues 21

High Cost of Products and Low Average Selling Prices 22

Two-Way Growing Competition 22

Stringent Regulatory Environment 23

Other Restraints 23

OPPORTUNITIES 24

Products 24

Applications and Geographic Expansion 24

IVUS VERSUS OTHER COMPETITIVE TECHNOLOGIES 25

IVUS VS OPTICAL COHERENCE TOMOGRAPHY (OCT) 25

IVUS VS FRACTIONAL FLOW RESERVE (FFR) 26

COST BENEFIT ANALYSIS 26

MARKET TRENDS 27

COMPETITIVE SCENARIO AND MARKET SHARE ANALYSIS 28

FIGURE 4 GLOBAL IVUS MARKET SHARE BY KEY MARKET PLAYERS, 2012 (%) 29

FIGURE 5 JAPANESE IVUS MARKET SHARE BY KEY MARKET PLAYERS, 2012 (%) 29

FIGURE 6 U.S. IVUS MARKET SHARE BY KEY MARKET PLAYERS, 2012 (%) 30

IVUS MARKET: THE ROAD AHEAD 30

RECOMMENDATIONS/STRATEGIES 31

CONSIDER MAKING EFFORTS TOWARD BETTER IMAGE INTERPRETATION 32

EXPLORE WAYS TO DEVELOP COMPETITIVE EDGE OVER COMPETING

TECHNOLOGIES IN THEIR OBSTACLE AREAS 32

INVESTIGATE THE TRAINING REQUIREMENTS OF DIFFERENT REGIONS

REGULARLY AND CONSIDER DEVELOPING TRAINING SERVICES

ACCORDINGLY

32

CONSIDER INVESTMENTS IN EMERGING ECONOMIES 32

FOCUS ON DEVELOPING MULTIMODALITY SYSTEMS 33

EXPLORE MARKETING AND PRODUCT DEVELOPMENT COLLABORATIONS 33

EVALUATE THE OPTIMAL SALES MODEL FOR RELATIVELY MORE POTENTIAL

REGIONS 33

FOCUS MORE ON DISSEMINATING IVUS BENEFITS THROUGH MULTIPLE

CHANNELS 34

CONSIDER INPUT OF KEY STAKEHOLDERS WHILE DEVELOPING PRODUCTS 34

PATENT ANALYSIS 34

FIGURE 7 PATENT ANALYSIS BY REGION, 2010-FEBRUARY 2013 (%) 34

CHAPTER 4 PRODUCTS MARKET 37

INTRODUCTION 37

DRIVERS 37

MARKET SCENARIO/INSIGHTS 37

TABLE 2 GLOBAL IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 38

TABLE 3 GLOBAL IVUS PRODUCTS MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 39

IVUS CONSOLES 39

KEY COMPETITIVE FACTORS 39

TABLE 4 GLOBAL IVUS CONSOLES MARKET BY TYPE OF CONSOLE, THROUGH 2017

($ MILLIONS) 40

TABLE 5 GLOBAL IVUS CONSOLES MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 40

DRIVERS, RESTRAINTS AND CHALLENGES 40

INTEGRATED VERSION - IVUS CONSOLES 41

TABLE 6 GLOBAL IVUS INTEGRATED CONSOLES MARKET BY REGION, THROUGH

2017 ($ MILLIONS) 42

CART IVUS CONSOLES 42

TABLE 7 GLOBAL CART IVUS CONSOLES MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 43

IVUS CATHETERS MARKET 43

DRIVERS AND RESTRAINTS 45

KEY COMPETITIVE FACTORS 45

TABLE 8 GLOBAL IVUS CATHETERS MARKET BY TYPE OF CATHETER, THROUGH

2017 ($ MILLIONS) 46

TABLE 9 GLOBAL IVUS CATHETERS MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 46

MECHANICAL (ROTATORY) CATHETERS 46

TABLE 10 GLOBAL IVUS MECHANICAL ROTATORY CATHETERS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 47

STATIC ELECTRONIC (PHASED ARRAY) CATHETERS 47

TABLE 11 GLOBAL IVUS STATIC ELECTRONIC (PHASED ARRAY) CATHETERS

MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 48

ACCESSORIES MARKET 48

TABLE 12 GLOBAL IVUS ACCESSORIES MARKET BY TYPE OF ACCESSORY,

THROUGH 2017 ($ MILLIONS) 48

TABLE 13 GLOBAL IVUS ACCESSORIES MARKET BY REGION THROUGH 2017 ($

MILLIONS) 49

PULLBACK DEVICES 49

GUIDEWIRES AND INTRODUCER SHEATH 50

OTHER DEVICES 50

SOFTWARE 50

DRIVERS 51

TABLE 14 GLOBAL IVUS SOFTWARE MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 52

SERVICES 52

TABLE 15 GLOBAL IVUS SERVICES MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 53

CHAPTER 5 END-USER MARKET 55

INTRODUCTION 55

DRIVERS AND RESTRAINTS 55

TABLE 16 GLOBAL IVUS MARKET BY END USERS, THROUGH 2017 ($ MILLIONS) 56

TABLE 17 GLOBAL IVUS END-USER MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 56

HOSPITALS 56

DRIVERS AND RESTRAINTS 57

TABLE 18 IVUS HOSPITAL END-USER MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 58

STAND-ALONE LABS 58

TABLE 19 GLOBAL IVUS STAND-ALONE LABS END-USER MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 58

RESEARCH CENTERS/ORGANIZATIONS 59

TABLE 20 IVUS RESEARCH CENTERS AND ORGANIZATIONS END-USER MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 60

COMMERCIAL ORGANIZATIONS 60

TABLE 21 IVUS COMMERCIAL ORGANIZATIONS END-USER MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 61

CHAPTER 6 APPLICATION MARKET 63

INTRODUCTION 63

TABLE 22 GLOBAL IVUS APPLICATION MARKET BY TYPES OF APPLICATIONS,

THROUGH 2017 ($ MILLIONS) 63

TABLE 23 GLOBAL IVUS APPLICATIONS MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 63

DRIVERS AND RESTRAINTS 64

CORONARY APPLICATIONS MARKET 64

TABLE 24 GLOBAL IVUS CORONARY APPLICATION MARKET BY TYPE OF

APPLICATION, THROUGH 2017 ($ MILLIONS) 65

TABLE 25 GLOBAL IVUS CORONARY APPLICATIONS MARKET BY REGION, THROUGH

2017 ($ MILLIONS) 65

IVUS CORONARY DIAGNOSTIC MARKET 65

TABLE 26 GLOBAL IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET BY TYPE

OF APPLICATION, THROUGH 2017 ($ MILLIONS) 66

TABLE 27 GLOBAL IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 66

Lesion Characterization/Decision on PCI Sizing and Strategy 67

TABLE 28 GLOBAL LESION CHARACTERIZATION/DECISION ON PCI SIZING AND

STRATEGY IVUS CORONARY INTERVENTION APPLICATIONS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS)

67

Assessment of Angiographically Indeterminate Lesions or Lesion

Significance 68

TABLE 29 GLOBAL ANGIOGRAPHICALLY INTERMEDIATE LESIONS/LESION

SIGNIFICANCE IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS)

69

Other Coronary IVUS Diagnostic Applications 69

TABLE 30 GLOBAL OTHER IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET

BY REGION, THROUGH 2017 ($ MILLIONS) 70

IVUS CORONARY INTERVENTION MARKET 70

TABLE 31 GLOBAL IVUS CORONARY INTERVENTIONS APPLICATIONS MARKET BY

TYPE OF APPLICATION, THROUGH 2017 ($ MILLIONS) 71

TABLE 32 GLOBAL IVUS CORONARY INTERVENTIONS APPLICATIONS MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 71

Guidance for Angioplasty 71

TABLE 33 GLOBAL GUIDANCE FOR ANGIOPLASTY IVUS CORONARY INTERVENTION

APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 72

Guidance for Plaque Modification 72

TABLE 34 GLOBAL GUIDANCE FOR PLAQUE MODIFICATION IVUS CORONARY

INTERVENTION APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 73

Stent Thrombosis and Restenosis 73

TABLE 35 GLOBAL STENT THROMBOSIS AND RESTENOSIS IVUS CORONARY

INTERVENTION APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 74

Other Coronary Interventional Applications 75

TABLE 36 GLOBAL OTHER IVUS CORONARY INTERVENTION APPLICATIONS MARKET

BY REGION, THROUGH 2017 ($ MILLIONS) 75

IVUS CORONARY RESEARCH MARKET 75

TABLE 37 GLOBAL IVUS CORONARY RESEARCH APPLICATIONS MARKET BY TYPE OF

AREA OF RESEARCH, THROUGH 2017 ($ MILLIONS) 76

TABLE 38 GLOBAL IVUS CORONARY RESEARCH APPLICATIONS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 76

Drug Discovery and Development 76

TABLE 39 GLOBAL DRUG DISCOVERY AND DEVELOPMENT IVUS CORONARY

RESEARCH APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 77

Angioplasty/Stent Evaluation 77

TABLE 40 GLOBAL ANGIOPLASTY/STENT EVALUATION IVUS CORONARY RESEARCH

APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 78

Atherosclerosis Process and Others 78

TABLE 41 GLOBAL ATHEROSCLEROSIS AND OTHER IVUS CORONARY

INTERVENTION APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 79

IVUS NONCORONARY/PERIPHERAL APPLICATIONS MARKET 80

DRIVERS 80

TABLE 42 GLOBAL IVUS NONCORONARY/PERIPHERAL APPLICATION MARKET BY

TYPE OF APPLICATION, THROUGH 2017 ($ MILLIONS) 81

TABLE 43 GLOBAL IVUS NONCORONARY/PERIPHERAL APPLICATIONS MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 81

IVUS Peripheral Diagnostics Applications 81

IVUS Peripheral Intervention Applications 82

IVUS Peripheral Research Applications 82

CHAPTER 7 COMPETITIVE DEVELOPMENTS 84

INTRODUCTION 84

FIGURE 8 DEVELOPMENTS IN GLOBAL INTRAVASCULAR ULTRASOUND MARKET,

2010-APRIL 15, 2013 (%) 84

TABLE 44 DEVELOPMENTS-PRODUCT LAUNCHES/INTRODUCTIONS, 2010-APRIL

2013 86

TABLE 45 DEVELOPMENTS - PARTNERSHIP, AGREEMENTS AND COLLABORATIONS,

2010-APRIL 2013 88

TABLE 46 DEVELOPMENTS - GEOGRAPHIC, SALES OR MANUFACTURING

EXPANSION, 2010-APRIL 2013 90

TABLE 47 DEVELOPMENTS - ACQUISITIONS, 2010-APRIL 2013 91

CHAPTER 8 GEOGRAPHICAL ANALYSIS 93

INTRODUCTION 93

JAPAN 93

DRIVERS AND RESTRAINTS 93

FIGURE 9 IVUS MARKET, JAPAN VERSUS GLOBAL, 2010-2017 ($ MILLIONS) 95

TABLE 48 JAPANESE IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 96

TABLE 49 JAPANESE IVUS MARKET BY APPLICATIONS, THROUGH 2017 ($ MILLIONS) 96

TABLE 50 JAPANESE IVUS MARKET BY END USERS, THROUGH 2017 ($ MILLIONS) 97

UNITED STATES (U.S.) 97

DRIVERS AND RESTRAINTS 97

FIGURE 10 U.S. IVUS MARKET, U.S. VERSUS GLOBAL, 2010-2017 ($ MILLIONS) 98

TABLE 51 U.S. IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 99

TABLE 52 U.S. IVUS MARKET BY APPLICATION, THROUGH 2017 ($ MILLIONS) 100

TABLE 53 U.S. IVUS MARKET BY END USER, THROUGH 2017 ($ MILLIONS) 100

EUROPE 100

DRIVERS AND RESTRAINTS 101

FIGURE 11 IVUS MARKET, EUROPE VERSUS GLOBAL, 2010-2017 ($ MILLIONS) 101

TABLE 54 EUROPEAN IVUS MARKET BY PRODUCT, THROUGH 2017 ($ MILLIONS) 103

TABLE 55 EUROPEAN IVUS MARKET BY APPLICATION, THROUGH 2017 ($ MILLIONS) 103

TABLE 56 EUROPEAN IVUS MARKET BY END USER, THROUGH 2017 ($ MILLIONS) 104

ASIA AND REST OF THE WORLD (ROW) 104

DRIVERS AND RESTRAINTS 104

FIGURE 12 IVUS MARKET, ASIA AND ROW VERSUS GLOBAL, 2010-2017 ($

MILLIONS) 105

TABLE 57 ASIAN AND ROW IVUS MARKET BY PRODUCT, THROUGH 2017 ($

MILLIONS) 106

TABLE 58 ASIAN AND ROW IVUS MARKET BY APPLICATION, THROUGH 2017 ($

MILLIONS) 107

TABLE 59 ASIAN AND ROW IVUS MARKET BY END USER, THROUGH 2017 ($

MILLIONS) 108

CHAPTER 9 PATENTS 110

TABLE 60 LIST OF U.S. PATENTS, 2010-2013 110

TABLE 61 LIST OF EUROPE PATENTS, 2010-2013 114

TABLE 62 LIST OF JAPAN PATENTS, 2010-2011 115

CHAPTER 10 COMPANY PROFILES 117

AVINGER, INC. 117

COMPANY OVERVIEW 117

BUSINESS AND PRODUCTS OVERVIEW 117

BUSINESS STRATEGY 117

BOSTON SCIENTIFIC CORPORATION 118

COMPANY OVERVIEW 118

BUSINESS OVERVIEW 118

PRODUCTS OVERVIEW 118

TABLE 63 BOSTON SCIENTIFIC CORPORATION IVUS AND RELATED PRODUCT

PORTFOLIO 119

FINANCIAL OVERVIEW 119

TABLE 64 BOSTON SCIENTIFIC CORPORATION NET SALES AND R&D EXPENDITURE,

2010-2012 ($ MILLIONS) 120

TABLE 65 BOSTON SCIENTIFIC CORPORATION NET SALES BY REGION, 2010-2012

($ MILLIONS) 120

TABLE 66 BOSTON SCIENTIFIC CORPORATION NET SALES BY BUSINESS SEGMENTS,

2010-2012 ($ MILLIONS) 120

BUSINESS STRATEGY 121

EV3 (COVIDIEN) 121

COMPANY OVERVIEW 121

BUSINESS AND PRODUCTS OVERVIEW 121

BUSINESS STRATEGY 122

GE HEALTHCARE 122

COMPANY AND FINANCIAL OVERVIEW 122

BUSINESS AND PRODUCTS OVERVIEW 122

BUSINESS STRATEGY 123

INFRAREDX, INC. 123

COMPANY OVERVIEW 123

BUSINESS AND PRODUCTS OVERVIEW 123

TABLE 67 INFRAREDX IVUS AND RELATED PRODUCT PORTFOLIO 124

BUSINESS STRATEGY 124

MEDTRONIC 125

COMPANY OVERVIEW 125

BUSINESS AND PRODUCTS OVERVIEW 125

BUSINESS STRATEGY 125

PHILIPS HEALTHCARE 126

COMPANY AND FINANCIAL OVERVIEW 126

BUSINESS AND PRODUCTS OVERVIEW 126

BUSINESS STRATEGY 126

PIE MEDICAL IMAGING BV 127

COMPANY OVERVIEW 127

BUSINESS AND PRODUCTS OVERVIEW 127

BUSINESS STRATEGY 128

SIEMENS HEALTHCARE DIAGNOSTICS, INC. (U.S.) 128

COMPANY AND FINANCIAL OVERVIEW 128

BUSINESS AND PRODUCTS OVERVIEW 128

BUSINESS STRATEGY 129

SILICON VALLEY MEDICAL INSTRUMENTS, INC. (SVMI) 129

COMPANY AND BUSINESS OVERVIEW 129

BUSINESS AND PRODUCTS OVERVIEW 129

BUSINESS STRATEGY 130

ST. JUDE MEDICAL 130

COMPANY OVERVIEW 130

BUSINESS OVERVIEW 131

PRODUCTS OVERVIEW 131

FINANCIAL OVERVIEW 131

BUSINESS STRATEGY 132

TERUMO CORPORATION 132

COMPANY OVERVIEW 132

BUSINESS OVERVIEW 132

PRODUCTS OVERVIEW 133

TABLE 68 TERUMO CORPORATION IVUS AND RELATED PRODUCT PORTFOLIO 133

TABLE 69 TERUMO CORPORATION NET SALES AND R&D EXPENDITURE, 2010-2012

(YEN MILLION) 134

TABLE 70 TERUMO CORPORATION NET SALES BY REGION, 2010-2012 (YEN BILLION) 134

TABLE 71 TERUMO CORPORATION NET SALES BY BUSINESS SEGMENTS, 2010-2012

(YEN BILLION) 134

BUSINESS STRATEGY 134

VOLCANO CORPORATION 135

COMPANY OVERVIEW 135

BUSINESS OVERVIEW 135

PRODUCTS OVERVIEW 135

TABLE 72 VOLCANO CORPORATION IVUS AND RELATED PRODUCT PORTFOLIO 136

FINANCIAL OVERVIEW 136

TABLE 73 VOLCANO CORPORATION REVENUES AND R&D EXPENDITURE,

2010-2012, AS OF DECEMBER 2012 ($ MILLIONS) 137

TABLE 74 VOLCANO CORPORATION REVENUES BY BUSINESS SEGMENTS,

2010-2012 ($ MILLIONS) 137

TABLE 75 VOLCANO CORPORATION REVENUES BY REGION, 2010-2012 ($

MILLIONS) 138

BUSINESS STRATEGY 138

 

LIST OF TABLES

 

SUMMARY TABLE GLOBAL IVUS PRODUCTS MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 7

TABLE 1 APPROXIMATE GLOBAL IVUS PENETRATION IN PCI 2012, BY REGION

(THOUSANDS/%) 21

TABLE 2 GLOBAL IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 38

TABLE 3 GLOBAL IVUS PRODUCTS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 39

TABLE 4 GLOBAL IVUS CONSOLES MARKET BY TYPE OF CONSOLE, THROUGH 2017

($ MILLIONS) 40

TABLE 5 GLOBAL IVUS CONSOLES MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 40

TABLE 6 GLOBAL IVUS INTEGRATED CONSOLES MARKET BY REGION, THROUGH

2017 ($ MILLIONS) 42

TABLE 7 GLOBAL CART IVUS CONSOLES MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 43

TABLE 8 GLOBAL IVUS CATHETERS MARKET BY TYPE OF CATHETER, THROUGH 2017

($ MILLIONS) 46

TABLE 9 GLOBAL IVUS CATHETERS MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 46

TABLE 10 GLOBAL IVUS MECHANICAL ROTATORY CATHETERS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 47

TABLE 11 GLOBAL IVUS STATIC ELECTRONIC (PHASED ARRAY) CATHETERS MARKET

BY REGION, THROUGH 2017 ($ MILLIONS) 48

TABLE 12 GLOBAL IVUS ACCESSORIES MARKET BY TYPE OF ACCESSORY, THROUGH

2017 ($ MILLIONS) 48

TABLE 13 GLOBAL IVUS ACCESSORIES MARKET BY REGION THROUGH 2017 ($

MILLIONS) 49

TABLE 14 GLOBAL IVUS SOFTWARE MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 52

TABLE 15 GLOBAL IVUS SERVICES MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 53

TABLE 16 GLOBAL IVUS MARKET BY END USERS, THROUGH 2017 ($ MILLIONS) 56

TABLE 17 GLOBAL IVUS END-USER MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 56

TABLE 18 IVUS HOSPITAL END-USER MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 58

TABLE 19 GLOBAL IVUS STAND-ALONE LABS END-USER MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 58

TABLE 20 IVUS RESEARCH CENTERS AND ORGANIZATIONS END-USER MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 60

TABLE 21 IVUS COMMERCIAL ORGANIZATIONS END-USER MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 61

TABLE 22 GLOBAL IVUS APPLICATION MARKET BY TYPES OF APPLICATIONS,

THROUGH 2017 ($ MILLIONS) 63

TABLE 23 GLOBAL IVUS APPLICATIONS MARKET BY REGION, THROUGH 2017 ($

MILLIONS) 63

TABLE 24 GLOBAL IVUS CORONARY APPLICATION MARKET BY TYPE OF APPLICATION,

THROUGH 2017 ($ MILLIONS) 65

TABLE 25 GLOBAL IVUS CORONARY APPLICATIONS MARKET BY REGION, THROUGH

2017 ($ MILLIONS) 65

TABLE 26 GLOBAL IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET BY TYPE OF

APPLICATION, THROUGH 2017 ($ MILLIONS) 66

TABLE 27 GLOBAL IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 66

TABLE 28 GLOBAL LESION CHARACTERIZATION/DECISION ON PCI SIZING AND

STRATEGY IVUS CORONARY INTERVENTION APPLICATIONS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS)

67

TABLE 29 GLOBAL ANGIOGRAPHICALLY INTERMEDIATE LESIONS/LESION

SIGNIFICANCE IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS)

69

TABLE 30 GLOBAL OTHER IVUS CORONARY DIAGNOSTIC APPLICATIONS MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 70

TABLE 31 GLOBAL IVUS CORONARY INTERVENTIONS APPLICATIONS MARKET BY

TYPE OF APPLICATION, THROUGH 2017 ($ MILLIONS) 71

TABLE 32 GLOBAL IVUS CORONARY INTERVENTIONS APPLICATIONS MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 71

TABLE 33 GLOBAL GUIDANCE FOR ANGIOPLASTY IVUS CORONARY INTERVENTION

APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 72

TABLE 34 GLOBAL GUIDANCE FOR PLAQUE MODIFICATION IVUS CORONARY

INTERVENTION APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 73

TABLE 35 GLOBAL STENT THROMBOSIS AND RESTENOSIS IVUS CORONARY

INTERVENTION APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 74

TABLE 36 GLOBAL OTHER IVUS CORONARY INTERVENTION APPLICATIONS MARKET

BY REGION, THROUGH 2017 ($ MILLIONS) 75

TABLE 37 GLOBAL IVUS CORONARY RESEARCH APPLICATIONS MARKET BY TYPE OF

AREA OF RESEARCH, THROUGH 2017 ($ MILLIONS) 76

TABLE 38 GLOBAL IVUS CORONARY RESEARCH APPLICATIONS MARKET BY REGION,

THROUGH 2017 ($ MILLIONS) 76

TABLE 39 GLOBAL DRUG DISCOVERY AND DEVELOPMENT IVUS CORONARY

RESEARCH APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 77

TABLE 40 GLOBAL ANGIOPLASTY/STENT EVALUATION IVUS CORONARY RESEARCH

APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 78

TABLE 41 GLOBAL ATHEROSCLEROSIS AND OTHER IVUS CORONARY INTERVENTION

APPLICATIONS MARKET BY REGION, THROUGH 2017 ($ MILLIONS) 79

TABLE 42 GLOBAL IVUS NONCORONARY/PERIPHERAL APPLICATION MARKET BY TYPE

OF APPLICATION, THROUGH 2017 ($ MILLIONS) 81

TABLE 43 GLOBAL IVUS NONCORONARY/PERIPHERAL APPLICATIONS MARKET BY

REGION, THROUGH 2017 ($ MILLIONS) 81

TABLE 44 DEVELOPMENTS-PRODUCT LAUNCHES/INTRODUCTIONS, 2010-APRIL 2013 86

TABLE 45 DEVELOPMENTS - PARTNERSHIP, AGREEMENTS AND COLLABORATIONS,

2010-APRIL 2013 88

TABLE 46 DEVELOPMENTS - GEOGRAPHIC, SALES OR MANUFACTURING EXPANSION,

2010-APRIL 2013 90

TABLE 47 DEVELOPMENTS - ACQUISITIONS, 2010-APRIL 2013 91

TABLE 48 JAPANESE IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 96

TABLE 49 JAPANESE IVUS MARKET BY APPLICATIONS, THROUGH 2017 ($ MILLIONS) 96

TABLE 50 JAPANESE IVUS MARKET BY END USERS, THROUGH 2017 ($ MILLIONS) 97

TABLE 51 U.S. IVUS MARKET BY PRODUCTS, THROUGH 2017 ($ MILLIONS) 99

TABLE 52 U.S. IVUS MARKET BY APPLICATION, THROUGH 2017 ($ MILLIONS) 100

TABLE 53 U.S. IVUS MARKET BY END USER, THROUGH 2017 ($ MILLIONS) 100

TABLE 54 EUROPEAN IVUS MARKET BY PRODUCT, THROUGH 2017 ($ MILLIONS) 103

TABLE 55 EUROPEAN IVUS MARKET BY APPLICATION, THROUGH 2017 ($ MILLIONS) 103

TABLE 56 EUROPEAN IVUS MARKET BY END USER, THROUGH 2017 ($ MILLIONS) 104

TABLE 57 ASIAN AND ROW IVUS MARKET BY PRODUCT, THROUGH 2017 ($ MILLIONS) 106

TABLE 58 ASIAN AND ROW IVUS MARKET BY APPLICATION, THROUGH 2017 ($

MILLIONS) 107

TABLE 59 ASIAN AND ROW IVUS MARKET BY END USER, THROUGH 2017 ($

MILLIONS) 108

TABLE 60 LIST OF U.S. PATENTS, 2010-2013 110

TABLE 61 LIST OF EUROPE PATENTS, 2010-2013 114

TABLE 62 LIST OF JAPAN PATENTS, 2010-2011 115

TABLE 63 BOSTON SCIENTIFIC CORPORATION IVUS AND RELATED PRODUCT

PORTFOLIO 119

TABLE 64 BOSTON SCIENTIFIC CORPORATION NET SALES AND R&D EXPENDITURE,

2010-2012 ($ MILLIONS) 120

TABLE 65 BOSTON SCIENTIFIC CORPORATION NET SALES BY REGION, 2010-2012 ($

MILLIONS) 120

TABLE 66 BOSTON SCIENTIFIC CORPORATION NET SALES BY BUSINESS SEGMENTS,

2010-2012 ($ MILLIONS) 120

TABLE 67 INFRAREDX IVUS AND RELATED PRODUCT PORTFOLIO 124

TABLE 68 TERUMO CORPORATION IVUS AND RELATED PRODUCT PORTFOLIO 133

TABLE 69 TERUMO CORPORATION NET SALES AND R&D EXPENDITURE, 2010-2012

(YEN MILLION) 134

TABLE 70 TERUMO CORPORATION NET SALES BY REGION, 2010-2012 (YEN BILLION) 134

TABLE 71 TERUMO CORPORATION NET SALES BY BUSINESS SEGMENTS, 2010-2012

(YEN BILLION) 134

TABLE 72 VOLCANO CORPORATION IVUS AND RELATED PRODUCT PORTFOLIO 136

TABLE 73 VOLCANO CORPORATION REVENUES AND R&D EXPENDITURE, 2010-2012,

AS OF DECEMBER 2012 ($ MILLIONS) 137

TABLE 74 VOLCANO CORPORATION REVENUES BY BUSINESS SEGMENTS, 2010-2012

($ MILLIONS) 137

TABLE 75 VOLCANO CORPORATION REVENUES BY REGION, 2010-2012 ($ MILLIONS) 138

 

LIST OF FIGURES

 

SUMMARY FIGURE GLOBAL IVUS PRODUCTS MARKET BY REGION, 2010-2017 ($

MILLIONS) 7

FIGURE 1 MARKET SHARE OF KEY PRODUCTS IN IVUS MARKET, 2012 (%) 11

FIGURE 2 KEY APPLICATIONS AREAS OF IVUS VERSUS TOTAL APPLICATION,

2010-2017 ($ MILLIONS) 13

FIGURE 3 MARKET SHARE OF KEY END USERS IN IVUS MARKET, 2012 (%) 14

FIGURE 4 GLOBAL IVUS MARKET SHARE BY KEY MARKET PLAYERS, 2012 (%) 29

FIGURE 5 JAPANESE IVUS MARKET SHARE BY KEY MARKET PLAYERS, 2012 (%) 29

FIGURE 6 U.S. IVUS MARKET SHARE BY KEY MARKET PLAYERS, 2012 (%) 30

FIGURE 7 PATENT ANALYSIS BY REGION, 2010-FEBRUARY 2013 (%) 34

FIGURE 8 DEVELOPMENTS IN GLOBAL INTRAVASCULAR ULTRASOUND MARKET,

2010-APRIL 15, 2013 (%) 84

FIGURE 9 IVUS MARKET, JAPAN VERSUS GLOBAL, 2010-2017 ($ MILLIONS) 95

FIGURE 10 U.S. IVUS MARKET, U.S. VERSUS GLOBAL, 2010-2017 ($ MILLIONS) 98

FIGURE 11 IVUS MARKET, EUROPE VERSUS GLOBAL, 2010-2017 ($ MILLIONS) 101

FIGURE 12 IVUS MARKET, ASIA AND ROW VERSUS GLOBAL, 2010-2017 ($ MILLIONS) 10

 

 

 

To order this report:

Medical_Imaging Industry: The Global Market for Intravascular Ultrasound Tools and Ancillary Equipment

 

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

 

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.